Human Virology and Viral Diseases
A section of Viruses (ISSN 1999-4915).
Section Information
Viruses have caused some of the most dramatic and deadly disease pandemics and epidemics the world has known. Subsequently, most of these causing agents have become common viruses with different epidemiological trends. The most recent trend has focused on emerging and re-emerging viruses and our related preparedness and response aspects. However, human virology goes beyond (re)-emerging viral diseases. This section aims at addressing all aspects of human viruses, medical virology and virus-induced clinical diseases. All types of manuscripts addressing a broad range of topics including epidemiology, prevention, diagnostics and treatment, will be considered in this section. Manuscripts must represent original and significant contributions.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Host-Mediated Viral Mutations: APOBECs, ADARs, and Beyond (Deadline: 31 March 2026)
- HPV-Associated Cancers 2026 (Deadline: 31 March 2026)
- HIV and Viral Hepatitis Co-Infection (Deadline: 31 March 2026)
- Advances in HSV (Deadline: 31 March 2026)
- Cascade of Care for HIV, Hepatitis and Sexually Transmitted Infections (Deadline: 31 March 2026)
- Lytic Cycle of Herpesviruses and the Associated Pathogenesis (Deadline: 31 March 2026)
- Viral Infections in Hematopoietic Stem Cell Transplant and Cellular Therapy Recipients, 2nd Edition (Deadline: 15 April 2026)
- Beyond Acute: Navigating Long COVID and Post-Viral Complications (Deadline: 15 April 2026)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 3.0 (Deadline: 20 April 2026)
- JC Polyomavirus (Deadline: 30 April 2026)
- Human T-Cell Leukemia Virus (HTLV) Infection and Treatment: 2nd Edition (Deadline: 30 April 2026)
- Virus-Associated Nephropathies (Deadline: 30 April 2026)
- Respiratory Syncytial Virus: Pathogenesis, Prevention and Treatment (Deadline: 30 April 2026)
- Human Cytomegalovirus Therapeutic Strategies and Clinical Applications (Deadline: 30 April 2026)
- Coxsackieviruses, Polioviruses and Associated Diseases (Second Edition) (Deadline: 1 May 2026)
- Research and Clinical Application of Adenovirus (AdV), 3rd Edition (Deadline: 20 May 2026)
- Cellular Mechanisms Regulating HIV Replication, 2nd Edition (Deadline: 20 May 2026)
- Hepatitis Virus Genetic Heterogeneity: Impact in Epidemiology and Clinical Pathology (Deadline: 31 May 2026)
- Current: Measles Outbreak, a Global Situation (Deadline: 31 May 2026)
- HIV Neurological Disorders: 2nd Edition (Deadline: 31 May 2026)
- EBV Infection and EBV-Associated Lymphomas in Children (Deadline: 31 May 2026)
- Hepatitis E: Molecular Virology, Pathogenesis, and Treatment, 3rd Edition (Deadline: 31 May 2026)
- Regulation of HIV-1 Transcription and Latency, 2nd Edition (Deadline: 31 May 2026)
- Oropouche Virus (OROV): An Emerging Peribunyavirus (Bunyavirus) (Deadline: 1 June 2026)
- Viral Infection and Platelets’ Disorders (Deadline: 30 June 2026)
- HIV Infection, Latency, Pathogenesis and Associated Comorbidities, Including Cancer and Inflammation in the Context of Drugs of Abuse and ART (Deadline: 30 June 2026)
- Oncogenic Infections and Cancer: Clinical Insights and Emerging Therapeutics (Deadline: 30 June 2026)
- Immune Responses to Papillomavirus Infections: 2nd Edition (Deadline: 30 June 2026)
- Advancing Research of Anelloviruses, Second Edition (Deadline: 30 June 2026)
- HIV and Drugs of Abuse, 4th Edition (Deadline: 30 June 2026)
- Advances in Research on HIV Drug Resistance and Other Determinants of Treatment Success: 3rd Edition (Deadline: 30 June 2026)
- Severe Fever with Thrombocytopenia Syndrome Virus 2026 (Deadline: 30 June 2026)
- Navigating Viral Threats: Enteric and Respiratory Viral Challenges in the Post-COVID-19 Era (Deadline: 30 June 2026)
- An Update on Enterovirus Research, 2nd Edition (Deadline: 30 June 2026)
- High Consequence Viral Transmission (Deadline: 17 July 2026)
- Congenital Cytomegalovirus Infection, 3rd Edition (Deadline: 31 July 2026)
- HIV in the Context of Chronic Disorders and Aging (Deadline: 31 July 2026)
- Zika Virus and Congenital Zika Syndrome, 2nd Edition (Deadline: 31 July 2026)
- Advancing Hepatitis Elimination: HBV, HDV, and HCV (Deadline: 31 July 2026)
- Translational Research in Virology (Deadline: 31 July 2026)
- RSV Epidemiological Surveillance: 3rd Edition (Deadline: 31 July 2026)
- Structural and Mechanistic Advances in Retroviral Biology (Deadline: 31 July 2026)
- Human Adenovirus (HAdV) Infection in Children (Deadline: 31 July 2026)
- Immune Modulation by Human Cytomegalovirus: 2nd Edition (Deadline: 1 August 2026)
- Hepatitis Viruses in Pathogenesis: Chronic Infection to Hepatocellular Carcinoma (Deadline: 31 August 2026)
- Mosquito-Borne Encephalitis Viruses: 2nd Edition (Deadline: 31 August 2026)
- Hepatitis Viruses: Detection, Diagnosis and Treatment (Deadline: 31 August 2026)
- Pathogenesis and Persistence in Flavivirus Infections: Mechanisms, Biomarkers, and Clinical Implications (Deadline: 31 August 2026)
- Long-Acting Antiretrovirals (Deadline: 31 August 2026)
- Hepatitis B Virus—Mechanisms of Persistence and Progress Towards a Cure (Deadline: 16 September 2026)
- Antigenic Drift in Respiratory Viruses (Deadline: 30 September 2026)
- Neuropathogenesis in HIV Infection: Mechanisms and Reservoirs (Deadline: 30 September 2026)
- Viruses Associated with Gastroenteritis: 2nd Edition (Deadline: 30 September 2026)
- Re-Emergence of Yellow Fever Virus (Deadline: 30 September 2026)
- Progress and Prospects in Oncolytic Virotherapy 2025–2026 (Deadline: 30 September 2026)
- Wastewater-Based Epidemiology and Viral Surveillance (Deadline: 30 September 2026)
- Unraveling Human Herpesviruses: From Molecular Mechanisms to Antiviral Approaches (Deadline: 30 September 2026)
- Enteric Viruses in Environment and Humans: Identification, Surveillance and Control (Deadline: 30 October 2026)
- Preparation for the Next Potential Pandemic—Chikungunya, Dengue, Zika and Other Viruses 2026 (Deadline: 31 October 2026)
- 70 Years of Rhinoviruses: From the Common Cold to Complex Pathogens (Deadline: 31 October 2026)
- Viruses and Eye Diseases, 2nd Edition (Deadline: 31 October 2026)
- Arbovirus Diagnosis (Deadline: 31 October 2026)
- Neurocognitive Dynamics and Biomarkers in HIV (Deadline: 1 November 2026)
- Cellular Immune Response to Hepatitis Viruses (Deadline: 30 November 2026)
- Human Metapneumovirus (HMPV) (Deadline: 30 November 2026)
- Molecular and Cellular Biology of Human Oncogenic Viruses: 2nd Edition (Deadline: 1 December 2026)
- Respiratory Viral Pathogenesis and Host-Microbe Crosstalk: From Bench to Bedside (Deadline: 1 December 2026)
- Human and Animal Papillomavirus: Infections, Genetics, and Vaccines (2nd Edition) (Deadline: 10 December 2026)
- The Ebola Legacy: Five Decades of Virological Breakthroughs (Deadline: 15 December 2026)
- Innovations and Emerging Challenges in Hepatitis C Virus Research (Deadline: 31 December 2026)
- Cell and Gene-Based Therapies for HIV (Deadline: 31 December 2026)
- Molecular Insights into HIV-1 Infection (Deadline: 31 December 2026)
- Epstein–Barr Virus: Mechanisms in Autoimmunity and Oncogenesis (Deadline: 31 December 2026)
- Epidemiology and Prevention of HIV/AIDS (Deadline: 31 December 2026)
- Viral Persistence and Transmission Dynamics of Immunocompromised Hosts: A Global Health Perspective (Deadline: 31 December 2026)
- Extrapulmonary Manifestations of Respiratory Viruses in Children (Deadline: 31 December 2026)
- COVID-19 Complications and Co-Infections: 2nd Edition (Deadline: 31 December 2026)
- Advances in Alphavirus and Flavivirus Research, 3rd Edition (Deadline: 31 December 2026)
- Current Trends in Arbovirus Outbreaks and Research (Deadline: 31 December 2026)
- HIV and HTLV Infections and Coinfections (2nd Edition) (Deadline: 1 January 2027)
- Impact of Evolution on Herpesvirus Pathogenesis (Deadline: 31 January 2027)
- Molecular Mechanisms and Clinical Manifestations of Persistent Viral Infections (2nd Edition) (Deadline: 1 February 2027)
- Hepatitis Viral Infections, Pathogenesis and Therapeutics (2nd Edition) (Deadline: 31 March 2027)
- Human T Cell Leukemia Virus (Deadline: 31 March 2027)
- The Interplay Between Viral Infections and Autoimmune Diseases (Deadline: 30 April 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
